We present a quantitative framework to model a Type II photodynamic therapy (PDT) process in the time domain in which a set of rate equations are solved to describe molecular reactions. Calculation of steady-state light distributions using a Monte Carlo method in a heterogeneous tissue phantom model demonstrates that the photon density differs significantly in a superficial tumor of only 3 mm thickness. The time dependences of the photosensitizer, oxygen and intracellular unoxidized receptor concentrations were obtained and monotonic decreases in the concentrations of the ground-state photosensitizer and receptor were observed. By defining respective decay times, we quantitatively studied the effects of photon density, drug dose and oxygen concentration on photobleaching and cytotoxicity of a photofrin-mediated PDT process. Comparison of the dependences of the receptor decay time on photon density and drug dose at different concentrations of oxygen clearly shows an oxygen threshold under which the receptor concentration remains constant or PDT exhibits no cytotoxicity. Furthermore, the dependence of the photosensitizer and receptor decay times on the drug dose and photon density suggests the possibility of PDT improvement by maximizing cytotoxicity in a tumor with optimized light and drug doses. We also discuss the utility of this model toward the understanding of clinical PDT treatment of chest wall recurrence of breast carcinoma.
INTRODUCTION
Photodynamic therapy (PDT) has attracted significant research efforts over the last two decades as an effective and viable modality for the treatment and management of superficial and luminal cancers by employing non-ionizing radiation of visible and nearinfrared light (1) . Compared to radiation therapy and chemotherapy, the clinical benefits of PDT for patients include tumorcidal activity and potentially reduced side effects. Most photosensitizer (PS) drugs used in clinical studies of PDT achieve tumor eradication by generating highly reactive oxygen molecules in the singlet excited states through a Type II process. The three essential components in this process are photons, PS and oxygen molecules. The reactions among themselves and with cells and vascular systems are the key to understanding the cytotoxicity and tissue necrosis caused by PDT. Although numerous reports have been published on various aspects of PDT processes, including laboratory and clinical settings, quantitative modeling of the dynamic process remains a challenging problem to be solved. A modeling framework allowing for a clear understanding of the fundamental processes should help improve the clinical efficacy and expand the range of PDT.
Accurate modeling of PDT processes requires the establishment of a framework to consider cytotoxicity as the result of molecular interaction with the photons being distributed in tissues. It is difficult to determine light distribution in the illuminated zone because most human tissues are optically turbid and heterogeneous in their optical properties. The size of the zone is typically much larger than the wavelengths of the optical radiation in visible and near-infrared spectral regions, which renders extremely difficult the modeling of light as electromagnetic fields. A radiative transfer equation (2) provides an efficient tool for solving light distribution problems in turbid tissues at macroscopic scales using the optical parameters of an absorption coefficient l a , a scattering coefficient l s and a scattering phase function p. But it is impossible to find analytical solutions to radiative transfer problems with practical boundary conditions, and numerical methods are necessary. Heterogeneity in the optical properties of normal and tumor tissues within an illuminated zone demands multiple sets of optical parameters, further increasing the difficulty for optical modeling. The complex interaction of the molecules poses another challenge for PDT modeling in which many aspects are yet to be clearly understood and quantitatively characterized. For example, how does the relaxation of excited PS and oxygen molecules influence the cytotoxicity, and what is the effect of photon-PS interaction on the tissue optical properties? Despite these difficult questions, the clinical outcomes of PDT have demonstrated significant benefits in the treatment of certain types of cancers compared to conventional modalities (3) . Clearly, a framework for modeling the complex PDT process will be useful for comprehending the vast amount of data from in vitro research using cultured cells and in vivo studies in animal models and clinics.
Coupled rate equations have been employed to understand the change of oxygen concentrations in the triplet ground state ( 3 O 2 ) and singlet excited state ( 1 O 2 ) during PDT treatment of cultured cell spheroids (4, 5) and cells (6) . This approach was extended to model the variations of both PS concentration and light distribution in a homogeneous tissue phantom due to different exciting light beam parameters based on a diffusion approximation to the radiative transfer theory (7, 8) . A similar model was proposed to obtain the photobleaching dose constant by solving the decay of the PS concentration with one rate equation with the assumption of a simple exponential distribution of light fluence rate along the incident beam direction (9) . In addition, PDT dosimetry under a pulsed illumination condition was studied with the diffusion model (10) . These efforts were focused on the modeling of the photobleaching process, and therefore, quantitative relation between singlet oxygen production and cytotoxicity remains poorly understood. Accurate modeling of the PDT process to improve upon previous efforts represents a significant step toward optimization of the PDT planning process in which, for example, one can maximize tumor response and reduce side effects by fully using the difference between the cytotoxicity in tumor and normal tissues.
We present here our initial results in establishing a framework of PDT modeling by combining Monte Carlo (MC) simulations with solving rate equations to understand a Type II Photofrin-mediated PDT process. Light distributions in a heterogeneous tumor phantom were numerically obtained for different cases of tissue optical parameters to study the range of photon density. Literature on PDT research was surveyed to select values of coefficients and parameters for solving a set of coupled rate equations in the time domain to quantitatively analyze the dynamic process of PS activation by photons and subsequent cytotoxicity. The decay times of PS and unoxidized receptor concentrations were defined to investigate the dependence of photobleaching and cytotoxicity on drug dose and photon density. We also discuss the utility of the framework in illustrating previous clinical results of chest wall treatment by PDT.
MATERIALS AND METHODS
A Type II PDT process involves the excitation of PS by photons and a cascading chain of reactions with singlet oxygen as the intermediate, leading to cytotoxicity and tissue necrosis. These events occur over drastically different spatial scales from the nanometer size of molecules to the millimeter size of photon scattering mean free path in the tissue. It has been demonstrated that diffusion can cause inhomogeneous distribution of oxygen at the micrometer scale of cells (4, 5) . Because we are primarily interested in the time dependence of the photodynamic process, the effect of oxygen diffusion and perfusion at the location r is approximately accounted for with a rate of change P in the corresponding rate equation. For a continuous-wave (cw) light source, therefore, we can separately consider the spatial and temporal dependence of the PDT process: the spatial dependence of light distribution in tissues is obtained through MC simulations, whereas the time dependences of the concentrations of PS and oxygen molecules at r are solved from a group of rate equations. The optical response of tissue and subsequent molecular interaction can be linked with the optical parameters of the tissue that are set as functions of both time and space. Because of the large difference between the spatial scales of molecular interaction and light distribution in tissue, the light distribution in terms of a photon density, q(r), should be regarded as a local quantity averaged over the submillimeter size of multicell clusters.
We adopted a rate-equation approach first used by Foster et al. (4) to solve for the time dependence of the molecular concentrations in a Type II PDT process as a consequence of the local photon density q(r) with six coupled, first-order differential equations. The PDT process is started by the absorption of photons by S 0 (the PS forms in their ground state) with an absorption cross-section, r psa . A schematic of the energy level diagram is presented in Fig. 1 to illustrate various pathways of the PDT process described by the rate equations. The concentrations of molecules in their ground and excited states are represented by their respective symbols in brackets and their rates of change are given by the following equations: Use of the efficiency factor a s instead of a k parameter for the bimolecular energy transfer from the excited PS to oxygen allows study of the effect of relaxation time s 3 on the excitation of oxygen. Among these equations, (Eq. 5) describes the photochemical processes that produce and consume 1 O 2 molecules. For example, the first and second terms on the right-hand side of (Eq. 5) are the rates of 1 O 2 consumption in photobleaching and oxidization of intracellular receptors. In addition, (Eq. 5) also includes the reaction of 1 O 2 with various oxygen scavengers with an average rate k sc and concentration [C] . The values of coefficients and parameters are listed in Table 1 and a detailed discussion on selecting these values is presented in the next section.
It has been widely accepted that the cytotoxicity induced in a Type II PDT process is caused primarily by the oxidization of various intracellular receptors at the PS binding sites, including those of the vasculature in the tumor, with the highly active 1 O 2 molecules (1, 11) . In response, various repair mechanisms can be activated within a cell to undo the cytotoxic damage. When the concentration of cytotoxic agents exceeds a certain threshold in a cell, irreversible apoptosis or necrosis occurs (12, 13) . Consequently, the time evolution of unoxidized receptors [R] should be determined by its reaction rate with 1 O 2 and a repair rate U as follows:
As a result, the time dependence of [R] can be related to cell survival in the time domain with a cell-killing model that is to be determined in the future. We point out that this model of the Type II PDT process presents a simplified picture of the actual PDT process consisting of different reacting molecules and receptors with a wide range of interactions. For example, the photobleaching or destruction of the PS can occur via two pathways depending on PS and its binding environment: one by photochemical reaction of S 0 with 1 O 2 , and the other independent of oxygen (14) . We limit our model on photobleaching to the former and described it by a reaction rate k pb in (Eq. 5). It is also possible that multiple types of intracellular receptors exist that react with 1 O 2 at different rates. Therefore, k cx and [R] should be regarded as the averaged values over different species of receptors involved in the PDT process. Despite these simplifications, different studies have demonstrated that the rate-equation approach provides a powerful tool for studying threshold problems of tissue damage by optical radiations such as PDT (4, 5) and pulsed laser ablation (15) . We thus believe that this approach will allow us to extract major characteristics of PDT without compromising the desired accuracy for explaining experimental data.
For cw light fields, a time-independent radiative transfer equation can be used to obtain light radiance L(r, s) at location r in a direction s within a tissue phantom as follows:
pðs; s9ÞLðr; s9Þd9 ð7Þ where p(s, s9) is the phase function describing the probability of light being scattered from s9 to s (2). The light distribution in a turbid medium such as human tissues on a macroscopic scale can be accurately solved by a statistical method of MC simulations based on the equation above (16, 17) . We have developed and validated an MC code to track photons in tissue phantoms through stochastic processes characterized by l s (r), l a (r) and p(s, s9) (18) (19) (20) . The basic algorithm uses a time-slicing method to efficiently tally the number of photons traversing through each cell of the computational grid dividing the tissue phantom after tracking each incident photon (18) . The output of our MC simulations are given in terms of a photon density function q(r) within the tissue phantom that is related to light radiance L(r, s) in (Eq. 7) by the following equation:
where h is the Planck constant, k is the light wavelength and v is the light speed in the tissue. For PDT modeling, q(r) should be interpreted as the local density of photons at the binding sites of PS. The function q(r) can be a slow-varying function of time due to the changes in tissue optical parameters as discussed below. To find the range of photon density in an illuminated zone that includes both tumor and normal tissues, such as the case with chest wall treatment (3), we employed a heterogeneous tissue model with a rectangular-shaped tumor embedded in a semi-infinite phantom of the normal tissue. The tissue phantom is shown in Fig. 2 with a diverging laser beam delivered from an optical fiber overlapping with the z-axis. The Henyey-Greenstein (H-G) function, p(h), was used as the phase function p(s, s9) in our MC code with the scattering angle h between s and s9 (21) . The H-G function is fully characterized by an anisotropy factor g, which is equal to the mean value of cosh. The heterogeneous tumor tissue phantom is described by l s and l a in the tumor region and by l s0 and l a0 in the normal tissue region. We assumed the same values of anisotropy factor g and refractive index n for both tumor and normal tissue regions. The differences in the optical parameters between tumor and normal tissues can be attributed to the physiological variations such as the extravasculature in the tumor and different PS uptake. Literature on the correlation between PS concentration and values of optical parameters of different tissues is quite limited. In vivo measurements of light radiance distribution in human subjects and animal models injected with different forms of PS can be inverted to obtain optical parameters based on Tested with a small value so that the repair effect can be neglected for t ,t max a diffusion approximation of the radiative equation (22) (23) (24) . These results suggested that l a is linearly related to the drug dose of PS in the tissues, whereas the reduced scattering coefficient l s 9 5 l s (1Àg) appears to be independent of the PS concentration at or near the wavelength corresponding to the absorption peak of PS. It has been found, however, that both optical parameters l a and l s 9 can be different in normal and tumor tissues due to different hemoglobin concentration and saturation (23, 25) . On the basis of these results, we considered two cases of different values of l a and l s in the normal and tumor regions of the tissue phantom to model tissue heterogeneity. Among these differences, we assumed that l a relates to the PS uptake as follows:
can also be used to check the consistency between the values of l a and l a0 used in the MC simulations and r psa in the rate equations for a given value of [S 0 ].
RESULTS
We chose a PS of porphyrin type such as Photofrin Ò for our model calculations for its status as the most established clinical PS. When data were not available, results reported with other PS types were used as the basis for selecting the appropriate values of the coefficients in (Eq. 1) to (Eq. 7), as discussed below and noted in Table 1 . It is well known that the molecular parameters of PDT processes vary in different cells and their environments and, therefore, uncertainty exists for choosing the parameter values. Consequently, one objective of this study was to test the ranges of critical parameter values so that the output from our model can be related to the results of cell and clinical studies.
We first investigated the range of photon density variation in the heterogeneous tissue phantom shown in Fig. 2 with our MC code based on (Eq. 7) and (Eq. 8) using the anisotropy factor g 5 0.80 and refractive index n 5 1.38 for both tumor and normal tissue regions. Other parameters of the phantom and the incident beam are given in the caption for Fig. 2 . The ranges of the tissue optical parameters were selected based on the values determined from bloodless porcine skin dermis tissues (26) plus blood (27) . In both cases, we assumed that [S 0 ] in the tumor region correspond to an injected dose of 2 mg/kg. The large fluctuation in small values for q is due to the variance in the MC results tracking a finite number of photons. For the region on top of the tumor (z 0.5 mm) the photon distributions q in the two cases were nearly identical, as expected. But q(0, 0, z) within the tumor between z 5 0.5 and 3.5 mm varies between 5.7 3 10 7 cm À3 and 1.8 3 10 6 cm À3 along the z-axis for the second case of r pss [S 0 ] 5 l a0 . The photon density variation in the x-y plane is much smaller within the tumor than that along the z-axis because of the uniform beam profile assumed for the diverging incident beam. These results demonstrate that variation in q is significant in the treated zone of a typical superficial tumor, by a factor of up to 30.
The system of the rate equations from (Eq. 1) to (Eq. 6) was solved to obtain the time dependence of various concentrations corresponding to the different locations inside the tissue phantom. We used an ordinary differential equation solver within the Matlab platform (ode15s of Matlab 6.5, MathWorks, Inc.) for a stiff system of equations with different time steps between 0 ns and t max 5 3000 s to achieve desired accuracy within the memory limit of the computer. Values of various coefficients and parameters were selected for the numerical solutions based on published reports, which are summarized below and listed fully in Table 1 .
The relaxation time of PS from S 1 to S 0 is given by s 1 , which has been estimated and measured (28) to be about 10 ns due to the fast transitions between the singlet states. In contrast, the relaxation time of the PS for intersystem crossing from T to S 0 , s 3 , has been reported to be ranging from microseconds to milliseconds (29) (30) (31) and two values of 30 or 300 ls for s 3 were examined in our modeling study. Fast relaxation of the singlet oxygen has been noted widely with s 0 estimated to be about less than 1 ls (29,30). We adopted s 0 5 30 ns in our calculations. The quantum yields of the S 1 to S 0 , T to S 0 for the PS and the 1 O 2 to 3 O 2 were set as g 10 5 0.2, g 30 5 0.3 and g 0 5 0.3, respectively (32-34), which led to g 13 5 1Àg 10 5 0.8. For simplicity, constant values were used for the rate of oxygen diffusion and perfusion P in (Eq. 4), the scavenger concentration, [C] 5 [C] i , in (Eq. 5) and the repair rate U in (Eq. 6). The value of P in (Eq. 4) was estimated from the reported values of oxygen diffusion constant (35) and oxygen concentration derivatives (5) Ò , can localize in mitochondrial membranes as the primary binding sites for PDT-induced apoptosis with high affinity for peripheral benzodiazepine receptors (37) (38) (39) . Therefore, the initial value of [R] for the intracellular concentration of singlet oxygen receptors was estimated from the morphological structure of the mitochondria. On the basis of an ultrastructural analysis of normal rat Leydig cells, it has been determined that the total area of mitochondrial membrane per cell is approximately around 3000 lm 2 (40) . By choosing the thickness of the membrane to be about 10 nm and the receptors' molecular weight at about 3000 (d), we set [R] i to be 5 3 10 17 cm
À3
. The values of other parameters and initial values of concentrations were estimated through a similar process and are noted in Table 1 . These initial estimations of the parameters will be improved continuously in the future as more relevant experimental results are identified in literature and acquired through our own laboratory studies. The concentration of the unoxidized receptors [R] shown in Fig.  4 remains at its initial value followed by a steep decrease that can be described by a power law as t Àp , with p ranging from 10 to 12. When [R] is reduced to about 10 À5 of its initial value, the repair term U in (Eq. 6) starts to dominate for t . , respectively, at t 5 0. These decay times are functions of initial drug dose and irradiance of incident light in terms of [S 0 ] i and q at the binding locations and thus were used to quantitatively study the phenomena of photobleaching and cytotoxicity in our modeling study. For example, it is easy to see in Fig. 4 that the value of s 3 primarily affects the transient behavior of the excited molecules. We also investigated the effect of different O 2 relaxation time with s 0 5 30 or 300 ns (not shown) and found that their effect on t S and t R is negligible. For the following results the values of s 3 5 300 ls and s 0 5 30 ns were adopted. Similar calculations were carried out to select the appropriate values of the parameters P and U. 
DISCUSSION
With more than two decades of active research, significant progress has been made to understand the fundamental photochemical and photobiological mechanisms underlying PDT. Despite the potential benefits that have been well recognized (1), PDT remains an underutilized treatment modality for patients with cancer. Major problems, in our view, may be related to the lack of tools to quantitative model light dosimetry and monitor PDT processes in clinics for optimized and reproducible response by patients. To overcome these difficulties, accurate models of PDT and tissue optics need to be developed. This report represents our first step toward this long-term goal by providing a framework to numerically study the light dosimetry in heterogeneous tissue phantom and its effect on cytotoxicity and photobleaching in a PDT process. Future improvement of modeling accuracy and efficiency with increased accuracy in rate equation parameters and parallel computing should help the expansion of PDT in the treatment and management of patients with cancer.
Current assessments of light dosimetry in PDT clinics are limited to the measurement of irradiance I 0 of the incident light beam and calculation of related fluence, F 5 R tmax 0 I 0 ðtÞdt 5 I 0 t max for an exposure time t max where I 0 is assumed as a constant for a cw light source. The MC method allows accurate calculations of the local photon density q(r) from a given I 0 , beam profile and tissue optical parameters. As we have shown in the coupled rate equations from (Eq. 1) to (Eq. 6), it is the q(r) that directly determines a local PDT process in a tissue. For t , t S , q(r) can be regarded as a steady-state distribution because the tissue optical parameters remain essentially the same because of negligible photobleaching. The results shown in Fig. 3 demonstrate a large variation in photon density in the embedded tumor within the first few millimeters of the surface. This requires the consideration of the PDT process as a local event.
We point out that the density of absorbed photons q a (r) should not be confused with q(r), which consists of the photons present at r. The two densities are related by the following equation:
where l a is due to the absorption of photons by PS and other chromophores.
The problem of quantitative modeling of cell-killing by singlet oxygen in a Type II PDT process remains unsolved. From the time evolution of unoxidized receptor concentration within a cell we extract a decay time t R in an attempt to characterize the cytotoxicity with a single parameter. Although cytotoxicity could be triggered well before the 1% of [R] i (5[R] (0)) is reached, the steep decrease in [R] for t ; t R (see Fig. 4 ) indicates that t R is insensitive to the choice of exact percentage. As a result, t R was used as a marker for the start of the cell-killing process to investigate the cytotoxicity of PDT as a function of q(r) and [S 0 , however, t R rapidly decreases as [S 0 ] i and q increases, as shown in Fig. 6 , and the data for t R become insensitive to the actual value of [ 3 O 2 ] i . These results are consistent with the well-known effect of oxygen and condition of hypoxia on cytotoxicity (41, 42) and the insensitivity of tumor cell survival ratios to the conditions of normobaric carbogen, and normobaric and hyperbaric oxygenation (43) in PDT. It is interesting to note from Fig. 6 that t S , t R for most combinations of [S 0 ] i and q. This indicates that combinations of PS drug and light doses may be explored to achieve cytotoxicity in a tumor without significant photobleaching. The effect of oxygen diffusion and perfusion was negligible in these calculations because of small P (see Table 1 ), which led to total contribution to [ 3 O 2 ] by diffusion and perfusion to be less than 1% of [ 3 O 2 ] i over a time window of 3000 s. We also studied the cases with P increased by factors of 5, 10 and 20 and found the results presented in Fig. 5 and 6 remain about the same.
PDT has been studied as a salvage procedure for patients with chest wall recurrence of breast carcinoma who failed multiple treatments by other modalities (3, 44) . Significant improvement in tumor response and reduction in post-treatment cutaneous morbidity rate was achieved with a low Photofrin dose of 0. Fig. 7 for three cases. In comparison with the drug dose of 0.8 mg/kg, the use of 2.0 mg/kg substantially increases the range of q in which t R , t max is satisfied and thus may lead to severe necrosis of normal tissues in the margin of tumor. This indicates that the practice of using low drug dose slightly above the threshold of tumor response could improve the prognosis of the patients by reducing the collateral tissue damage without compromising the killing of tumor cells.
For the results presented in this report, we assumed that [S 0 ] does not change notably over the time window of interest due to photobleaching effect so that l a in (Eq. 9) can be treated as constants. This is certainly the case for t ( t S or the negligible contribution to l a by [S 0 ]. For other cases in our discussions it has been verified that the changes of q due to different [S 0 ] were very small in comparison to its value at t 5 0 on the z-axis of the tissue phantom. We also note that our model is capable of taking into account the time dependence of Preliminary results of parallel MC simulations (47) indicated that the simulation time can be reduced to less than 3 min on a computing cluster of 16 processing elements with the same CPUs.
In summary, we have demonstrated the feasibility of modeling a Type II Photofrin-mediated PDT process by solving a set of rate equations to obtain the time dependence of the PS, oxygen and intracellular unoxidized receptors. Light distributions in a heterogeneous tissue phantom were calculated using an MC method. Based on these results, decay times were defined for the concentrations of the PS drug and receptors as the metrics to characterize photobleaching and cytotoxicity. With this approach we calculated the decay times as the functions of the drug dose and photon density at different concentrations of oxygen, which can be used to quantitatively investigate the photobleaching and cytotoxicity effect. A threshold of oxygen was identified in our model under which no cytotoxicity can be observed and the decay times become insensitive to the oxygen concentration once it exceeds the threshold. The potential clinical utility of this PDT model is exemplified in the explanation of patient outcomes from PDT treatment of chest wall recurrence of breast carcinoma.
